安徽医药
安徽醫藥
안휘의약
ANHUI MEDICAL AND PHARMACEUTICAL JOURNAL
2015年
5期
895-898
,共4页
人工晶状体%白内障%高度近视%超声乳化
人工晶狀體%白內障%高度近視%超聲乳化
인공정상체%백내장%고도근시%초성유화
intraocular lens%cataract%high myopia%phacoemulsification
目的:探讨高度近视并发性白内障行超声乳化吸出植入Bigbag及MI60两种人工晶体后的早期临床疗效。方法分析该科高度近视并发性白内障行超声乳化吸出并植人工晶体83例(117眼)。其中植入Bigbag人工晶体44例(61眼)为A组,植入MI60人工晶体39例(56眼)为B组。记录两组围手术期相关评价指标:眼轴及前房深度、裸眼视力、最佳矫正视力、对比敏感度、屈光状态、晶体位置、并发症等。结果(1)术后6个月两组前房深度较术前增加,同时组间有统计学意义(P<0.01)。术后6个月与术前玻璃体腔前后径(视轴区后囊膜至视网膜的距离)的差值:B组(4.51±0.81)mm明显大于A组(2.92±0.79)mm,P<0.01。(2)两组术后6个月实际屈光度与术前预留屈光度差值:A组≤±1.0D有43眼(70.49%),B组≤±1.0D 有32眼(57.14%)。(3)两组术后裸眼视力较术前改善明显(P<0.01);两组术后6个月BCVA(最佳矫正视力)及对比度视力均无统计学意义(P>0.05),术后主观视觉问卷调查显示A组满意度高于B组。(4)并发症:A组后囊膜混浊4例、玻璃体后脱离2例;B组后囊膜混浊5例、人工晶体偏心1例、玻璃体后脱离5例。结论高度近视性白内障植入特殊设计的Bigbag人工晶体使手术前后前房深度、玻璃体腔前后径的改变较小,预留晶体度数更准确,术后视力提高明显,主观满意度较高。
目的:探討高度近視併髮性白內障行超聲乳化吸齣植入Bigbag及MI60兩種人工晶體後的早期臨床療效。方法分析該科高度近視併髮性白內障行超聲乳化吸齣併植人工晶體83例(117眼)。其中植入Bigbag人工晶體44例(61眼)為A組,植入MI60人工晶體39例(56眼)為B組。記錄兩組圍手術期相關評價指標:眼軸及前房深度、裸眼視力、最佳矯正視力、對比敏感度、屈光狀態、晶體位置、併髮癥等。結果(1)術後6箇月兩組前房深度較術前增加,同時組間有統計學意義(P<0.01)。術後6箇月與術前玻璃體腔前後徑(視軸區後囊膜至視網膜的距離)的差值:B組(4.51±0.81)mm明顯大于A組(2.92±0.79)mm,P<0.01。(2)兩組術後6箇月實際屈光度與術前預留屈光度差值:A組≤±1.0D有43眼(70.49%),B組≤±1.0D 有32眼(57.14%)。(3)兩組術後裸眼視力較術前改善明顯(P<0.01);兩組術後6箇月BCVA(最佳矯正視力)及對比度視力均無統計學意義(P>0.05),術後主觀視覺問捲調查顯示A組滿意度高于B組。(4)併髮癥:A組後囊膜混濁4例、玻璃體後脫離2例;B組後囊膜混濁5例、人工晶體偏心1例、玻璃體後脫離5例。結論高度近視性白內障植入特殊設計的Bigbag人工晶體使手術前後前房深度、玻璃體腔前後徑的改變較小,預留晶體度數更準確,術後視力提高明顯,主觀滿意度較高。
목적:탐토고도근시병발성백내장행초성유화흡출식입Bigbag급MI60량충인공정체후적조기림상료효。방법분석해과고도근시병발성백내장행초성유화흡출병식인공정체83례(117안)。기중식입Bigbag인공정체44례(61안)위A조,식입MI60인공정체39례(56안)위B조。기록량조위수술기상관평개지표:안축급전방심도、라안시력、최가교정시력、대비민감도、굴광상태、정체위치、병발증등。결과(1)술후6개월량조전방심도교술전증가,동시조간유통계학의의(P<0.01)。술후6개월여술전파리체강전후경(시축구후낭막지시망막적거리)적차치:B조(4.51±0.81)mm명현대우A조(2.92±0.79)mm,P<0.01。(2)량조술후6개월실제굴광도여술전예류굴광도차치:A조≤±1.0D유43안(70.49%),B조≤±1.0D 유32안(57.14%)。(3)량조술후라안시력교술전개선명현(P<0.01);량조술후6개월BCVA(최가교정시력)급대비도시력균무통계학의의(P>0.05),술후주관시각문권조사현시A조만의도고우B조。(4)병발증:A조후낭막혼탁4례、파리체후탈리2례;B조후낭막혼탁5례、인공정체편심1례、파리체후탈리5례。결론고도근시성백내장식입특수설계적Bigbag인공정체사수술전후전방심도、파리체강전후경적개변교소,예류정체도수경준학,술후시력제고명현,주관만의도교고。
Objective To discuss and explore the early clinical effects between the Bigbag and MI60 intraocluar lens (IOL)implanta-tion in cataract patients with high myopia.Methods We investigated the clinical data of 83 patients who had received phacoemulsifica-tion and IOL implantation.The patients were divided into two groups:group A (n=44,61 eyes)all used the Bigbag IOL and group B (n=39,56 eyes)all used MI60 IOL.Preoperative and postoperative axial length,anterior chamber depth,visual acuity,BCVA (best corrected visual acuity),contrast sensitivity,refractive status were recorded.Position of the intraoeular lens and postoperative complica-tions were observed.Results (1 )The postoperative anterior chamber increased in two groups than preoperative one,and group B in-creased more significantly than group A (P <0.05).The variations in distance from the posterior capsule membrane to the retina were significantly different between group A (2.92 ±0.79)mm and group B (4.51 ±0.81)mm.(2)The diopter of refractive error 6 months after surgery:43 eyes (70.46%)of bigbag group were within 1.0 D,and 32 eyes (57.14%)of M160 group were within 1.0 D.(3)The postoperative visual acuity of two groups was improved significantly compared with the preoperative (P<0.05),but there was no signif-icant difference on best corrected visual acuilty and curves of contrast sensitivity.Postoperative subjective visual satisfaction in group A was superior to group B.(4)Complications:goup A has 4 cases of capsular opacification and 2 cases of posterior vitreous detachment;group B has 5 cases of capsular opacification,1 case of IOL deviation,and 5 cases of posterior vitreous detachment.Conclusions This clinical research showed Bigbag IOL is more suitable than MI60 IOL in cataract patients with high myopia,which is more effective and safe.